Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia – New England Journal of Medicine News release: Data Published in New England Journal of Medicine Shows Pfizer’s Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumonia   Commentary on Twitter: Patients who were hospitalized with #COVID19 pneumonia were randomly assigned, at a median […]

The post RCT: Tofacitinib reduced the risk of death or respiratory failure in patients hospitalized with Covid-19 pneumonia. appeared first on Links Medicus.